Back to Journals » International Journal of Chronic Obstructive Pulmonary Disease » Volume 13

Indacaterol/glycopyrronium reduces the risk of clinically important deterioration after direct switch from baseline therapies in patients with moderate COPD: a post hoc analysis of the CRYSTAL study

Total article views   HTML views PDF downloads Totals
10,780 Dovepress* 9,889+ 1,899 11,788
PubMed Central* 891 413 1,304
Totals 10,780 2,312 13,092
*Since 16 April 2018
Total mentioned Facebook Delicious Reddit Twitter Others
24 0 0 0 12 12

View citations on PubMed Central and Google Scholar